XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 2,347,000 $ 1,701,000
Marketable securities 62,000 2,276,000
Prepaid expenses and other current assets 166,000 199,000
Total current assets 2,575,000 4,176,000
Property and equipment, net 80,000 108,000
Right of use asset, net 436,000 618,000
Patent and trademark rights, net 2,041,000 2,594,000
Other assets 362,000 1,112,000
Total assets 5,494,000 8,608,000
Current liabilities:    
Accounts payable 1,252,000 6,383,000
Accrued expenses 679,000 606,000
Current portion of operating lease liability 232,000 239,000
Current portion of note payable, net 1,880,000 2,307,000
Total current liabilities 4,043,000 9,535,000
Long-term liabilities:    
Operating lease liability 226,000 395,000
Warrant liability 7,302,000
Total liabilities 11,571,000 9,930,000
Commitments and contingencies (Note 10 and 11)
Stockholders’ deficit:    
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 2,764,188 and 655,263 as of September 30, 2025 and December 31, 2024, respectively 3,000 1,000
Additional paid-in capital 430,531,000 425,505,000
Accumulated deficit (436,611,000) (426,828,000)
Total stockholders’ equity (6,077,000) (1,322,000)
Total liabilities and stockholders’ equity 5,494,000 8,608,000
Series A Junior Participating Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred Stock, Value
Series B Convertible Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred Stock, Value